NGM Biopharmaceuticals, Inc.
NASDAQ:NGM
1.54 (USD) • At close April 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.165 | 0.582 | 1.423 | 2.247 | 18.181 | 7.911 | 8.293 | 20.948 | 20.959 | 18.575 | 16.773 | 21.575 | 19.767 | 23.482 | 19.755 | 24.364 | 31.083 | 21.568 | 25.341 | 25.552 | 47.119 | 20.815 | 22.118 | 18.613 |
| Cost of Revenue
| 0.518 | 0.5 | 1.119 | 1.119 | 1.114 | 1.092 | 1.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.353 | 0.082 | 0.304 | 1.128 | 17.067 | 6.819 | 6.893 | 20.948 | 20.959 | 18.575 | 16.773 | 21.575 | 19.767 | 23.482 | 19.755 | 24.364 | 31.083 | 21.568 | 25.341 | 25.552 | 47.119 | 20.815 | 22.118 | 18.613 |
| Gross Profit Ratio
| -2.139 | 0.141 | 0.214 | 0.502 | 0.939 | 0.862 | 0.831 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 21.372 | 22.942 | 32.351 | 40.857 | 46.722 | 46.106 | 45.433 | 42.806 | 38.729 | 38.714 | 43.57 | 40.699 | 40.06 | 46.979 | 38.494 | 38.439 | 41.954 | 28.953 | 28.819 | 29.527 | 28.941 | 24.473 | 22.846 | 19.454 |
| General & Administrative Expenses
| 7.938 | 8.671 | 9.647 | 11.584 | 9.756 | 10.109 | 9.927 | 10.723 | 9.454 | 8.867 | 9.823 | 8.721 | 7.38 | 6.46 | 6.794 | 6.595 | 6.423 | 5.612 | 6.229 | 5.367 | 5.122 | 4.811 | 3.458 | 3.874 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.938 | 8.671 | 9.647 | 11.584 | 9.756 | 10.109 | 9.927 | 10.723 | 9.454 | 8.867 | 9.823 | 8.721 | 7.38 | 6.46 | 6.794 | 6.595 | 6.423 | 5.612 | 6.229 | 5.367 | 5.122 | 4.811 | 3.458 | 3.874 |
| Other Expenses
| -0.048 | -0.015 | -0.134 | -0.037 | -0.17 | 0.078 | 0.005 | -0.045 | -0.095 | 0.035 | -0.187 | 0.187 | -0.434 | -0.068 | -0.471 | 0.38 | -0.201 | 0.096 | -0.006 | -0.036 | 0.096 | -0.014 | 0.095 | 0.022 |
| Operating Expenses
| 29.31 | 31.613 | 41.998 | 52.441 | 56.478 | 56.215 | 55.36 | 53.529 | 48.183 | 47.581 | 53.393 | 49.42 | 47.44 | 53.439 | 45.288 | 45.034 | 48.377 | 34.565 | 35.048 | 34.894 | 34.063 | 29.284 | 26.304 | 23.328 |
| Operating Income
| -29.663 | -31.031 | -40.575 | -50.194 | -38.297 | -48.304 | -47.067 | -32.581 | -27.224 | -29.006 | -36.62 | -27.845 | -27.673 | -29.957 | -25.533 | -20.67 | -17.294 | -12.997 | -9.707 | -9.342 | 13.056 | -8.469 | -4.186 | -4.715 |
| Operating Income Ratio
| -179.776 | -53.318 | -28.514 | -22.338 | -2.106 | -6.106 | -5.676 | -1.555 | -1.299 | -1.562 | -2.183 | -1.291 | -1.4 | -1.276 | -1.292 | -0.848 | -0.556 | -0.603 | -0.383 | -0.366 | 0.277 | -0.407 | -0.189 | -0.253 |
| Total Other Income Expenses Net
| 1.993 | 2.234 | 2.314 | 2.547 | 1.86 | 1.043 | 0.548 | 0.131 | -0.01 | 0.141 | -0.072 | 0.301 | -0.318 | 0.192 | -0.083 | 1.555 | 1.353 | 2.08 | 2.038 | 1.074 | 1.109 | 0.952 | 0.986 | 0.774 |
| Income Before Tax
| -27.67 | -28.797 | -38.261 | -47.647 | -36.437 | -47.261 | -46.519 | -32.45 | -27.234 | -28.865 | -36.692 | -27.544 | -27.991 | -29.765 | -25.616 | -19.115 | -15.941 | -10.917 | -7.669 | -8.268 | 14.165 | -7.517 | -3.2 | -3.941 |
| Income Before Tax Ratio
| -167.697 | -49.479 | -26.888 | -21.205 | -2.004 | -5.974 | -5.609 | -1.549 | -1.299 | -1.554 | -2.188 | -1.277 | -1.416 | -1.268 | -1.297 | -0.785 | -0.513 | -0.506 | -0.303 | -0.324 | 0.301 | -0.361 | -0.145 | -0.212 |
| Income Tax Expense
| 7.244 | -2.249 | -2.448 | -2.547 | -1.86 | -1.043 | -0.548 | -0.131 | -27.234 | -0.106 | -0.115 | -0.114 | -1.669 | -0.26 | -0.388 | -1.175 | -3.321 | -1.984 | -2.044 | -1.11 | -1.013 | -0.966 | -0.891 | -0.752 |
| Net Income
| -27.67 | -28.797 | -38.261 | -45.1 | -34.577 | -46.218 | -45.971 | -32.319 | -27.234 | -28.865 | -36.692 | -27.544 | -27.991 | -29.765 | -25.616 | -19.115 | -15.941 | -10.917 | -7.669 | -8.268 | 14.165 | -7.517 | -3.2 | -3.941 |
| Net Income Ratio
| -167.697 | -49.479 | -26.888 | -20.071 | -1.902 | -5.842 | -5.543 | -1.543 | -1.299 | -1.554 | -2.188 | -1.277 | -1.416 | -1.268 | -1.297 | -0.785 | -0.513 | -0.506 | -0.303 | -0.324 | 0.301 | -0.361 | -0.145 | -0.212 |
| EPS
| -0.33 | -0.35 | -0.46 | -0.55 | -0.42 | -0.57 | -0.58 | -0.41 | -0.35 | -0.37 | -0.48 | -0.36 | -0.4 | -0.43 | -0.38 | -0.28 | -0.24 | -0.17 | -0.12 | -0.13 | 0.26 | -0.14 | -0.06 | -0.074 |
| EPS Diluted
| -0.33 | -0.35 | -0.46 | -0.55 | -0.42 | -0.57 | -0.58 | -0.41 | -0.35 | -0.37 | -0.48 | -0.36 | -0.4 | -0.43 | -0.38 | -0.28 | -0.24 | -0.17 | -0.12 | -0.13 | 0.26 | -0.14 | -0.06 | -0.074 |
| EBITDA
| -29.145 | -30.496 | -40.016 | -50.194 | -38.297 | -47.706 | -45.671 | -31.154 | -27.224 | -27.514 | -35.056 | -26.291 | -27.673 | -28.336 | -23.883 | -18.939 | -17.294 | -11.055 | -7.772 | -7.381 | 14.947 | -6.59 | -2.476 | -2.972 |
| EBITDA Ratio
| -176.636 | -52.399 | -28.121 | -22.338 | -2.106 | -6.03 | -5.507 | -1.487 | -1.299 | -1.481 | -2.09 | -1.219 | -1.4 | -1.207 | -1.209 | -0.777 | -0.556 | -0.513 | -0.307 | -0.289 | 0.317 | -0.317 | -0.112 | -0.16 |